Abstract
Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in young adults and children in the industrialized countries; however, there are presently no FDA approved therapies. TBI results in oxidative stress due to the overproduction of reactive oxygen species and overwhelming of the endogenous antioxidant mechanisms. Recently, it has been reported that antioxidants including phytochemicals have a protective role against oxidative damage and inflammation after TBI. To analyze the effects of a naturally occurring antioxidant molecule, allyl isothiocyanate (AITC), on the nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor kappa B (NF-κB) signaling pathways in TBI, a cryogenic injury model was induced in mice. Here, we showed that AITC administered immediately after the injury significantly decreased infarct volume and blood–brain barrier (BBB) permeability. Protein levels of proinflammatory cytokines interleukin-1β (IL1β) and interleukin-6 (IL6), glial fibrillary acidic protein (GFAP) and NF-κB were decreased, while Nrf2, growth-associated protein 43 (GAP43) and neural cell adhesion molecule levels were increased with AITC when compared with vehicle control. Our results demonstrated that the antioxidant molecule AITC, when applied immediately after TBI, provided beneficial effects on inflammatory processes while improving infarct volume and BBB permeability. Increased levels of plasticity markers, as well as an antioxidant gene regulator, Nrf2, by AITC, suggest that future studies are warranted to assess the protective activities of dietary or medicinal AITC in clinical studies.
Graphical abstract
Similar content being viewed by others
Abbreviations
- AITC:
-
Allyl isothiocyanate
- BBB:
-
Blood–brain barrier
- GAP43:
-
Growth-associated protein 43
- GFAP:
-
Glial fibrillary acidic protein
- ICAM-1:
-
Intercellular adhesion molecule-1
- IL1β:
-
Interleukin-1β
- IL6:
-
Interleukin-6
- NCAM:
-
Neural cell adhesion molecule
- NF-κB:
-
Nuclear factor kappa B
- Nrf2:
-
Nuclear factor erythroid 2-related factor 2
- ROS:
-
Reactive oxygen species
- TBI:
-
Traumatic brain injury
References
Dixon KJ (2017) Pathophysiology of traumatic brain injury. Phys Med Rehabil Clin N Am 28(2):215–225
Colantonio A, Croxford R, Farooq S, Laporte A, Coyte PC (2009) Trends in hospitalization associated with traumatic brain injury in a publicly insured population, 1992–2002. J Trauma 66:179–183
Maas AI, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. Lancet Neurol 7(8):728–741
Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, Dowell A, Brown P, Parag V, Kydd R, Jones K, Jones A, Ameratunga S, BIONIC Study Group (2013) Incidence of traumatic brain injury in New Zealand: a population-based study. Lancet Neurol 12:53–64
The Lancet Neurology (2010) Traumatic brain injury: time to end the silence. Lancet Neurol 9:331
Andriessen TM, Jacobs B, Vos PE (2010) Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 14:2381–2392
Winkler EA, Minter D, Yue JK, Manley GT (2016) Cerebral edema in traumatic brain injury: pathophysiology and prospective therapeutic targets. Neurosurg Clin N Am 27(4):473–488
Abdul-Muneer PM, Chandra N, Haorah J (2015) Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol 51(3):966–979
Hergenroeder GW, Redell JB, Moore AN, Dash PK (2008) Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol Diagn Ther 12(6):345–358
Conaway CC, Yang YM, Chung FL (2002) Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3:233–255
Xiao D, Srivastava SK, Lew KL, Zeng Y, Hershberger P, Johnson CS, Trump DL, Singh SV (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 24(5):891–897
Tang L, Zhang Y (2004) Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr 134(8):2004–2010
Smith T, Musk SRR, Johnson IT (1996) Allyl isothiocyanate selectively kills undifferentiated HT29 cells in vitro and suppresses aberrant crypt foci in the colonic mucosa of rats. Biochem Soc Trans 24(3):381S
Smith TK, Lund EK, Parker ML, Clarke RG, Johnson IT (2004) Allyl-isothiocyanate causes mitotic block, loss of cell adhesion and disrupted cytoskeletal structure in HT29 cells. Carcinogenesis 25(8):1409–1415
Ernst IM, Wagner AE, Schuemann C, Storm N, Höppner W, Doring F, Stocker A, Rimbach G (2011) Allyl-, butyl- and phenylethyl-isothiocyanate activate Nrf2 in cultured fibroblasts. Pharmacol Res 63(3):233–240
Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284(20):13291–13295
Yehuda H, Soroka Y, Zlotkin-Frušić M, Gilhar A, Milner Y, Tamir S (2012) Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin. Inflamm Res 61(7):735–742
Lafrenaye AD, Todani M, Walker SA, Povlishock JT (2015) Microglia processes associate with diffusely injured axons following mild traumatic brain injury in the micro pig. J Neuroinflamm 12:186
Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, McRoberts JA (2008) Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J Neurogenet 22(4):315–331
Jennings M, Batchelor GR, Brain PF, Dick A, Elliott H, Francis RJ, Hubrecht RC, Hurst JL, Morton DB, Peters AG (1998) Refining rodent husbandry: the mouse. report of the rodent refinement working party. Lab Anim 32:233–259
Peirson SN, Brown LA, Pothecary CA, Benson LA, Fisk AS (2018) Light and the laboratory mouse. J Neurosci Methods 300:26–36
Kelestemur T, Yulug B, Caglayan AB, Beker MC, Kilic U, Caglayan B, Yalcin E, Gundogdu RZ, Kilic E (2016) Targeting different pathophysiological events after traumatic brain injury in mice: role of melatonin and memantine. Neurosci Lett 612:92–97
Trevisan G, Rossato MF, Hoffmeister C, Oliveira SM, Silva CR, Matheus FC, Mello GC, Antunes E, Prediger RD, Ferreira J (2013) Mechanisms involved in abdominal nociception induced by either TRPV1 or TRPA1 stimulation of rat peritoneum. Eur J Pharmacol 714(1–3):332–344
Beker MC, Caglayan AB, Kelestemur T, Caglayan B, Yalcin E, Yulug B, Kilic U, Hermann DM, Kilic E (2015) Effects of normobaric oxygen and melatonin on reperfusion injury: role of cerebral microcirculation. Oncotarget 6(31):30604–30614
Beker MC, Caglayan B, Yalcin E, Caglayan AB, Turkseven S, Gurel B, Kelestemur T, Sertel E, Sahin Z, Kutlu S, Kilic U, Baykal AT, Kilic E (2018) Time-of-day dependent neuronal injury after ischemic stroke: implication of circadian clock transcriptional factor Bmal1 and survival kinase AKT. Mol Neurobiol 55(3):2565–2576
Caglayan B, Caglayan AB, Beker MC, Yalcin E, Beker M, Kelestemur T, Sertel E, Ozturk G, Kilic U, Sahin F, Kilic E (2017) Evidence that activation of P2 × 7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice. Exp Neurol 296:23–31
Hulsebosch CE, DeWitt DS, Jenkins LW, Prough DS (1998) Traumatic brain injury in rats results in increased expression of Gap-43 that correlates with behavioral recovery. Neurosci Lett 255(2):83–86
Boutin C, Schmitz B, Cremer H, Diestel S (2009) NCAM expression induces neurogenesis in vivo. Eur J Neurosci 30(7):1209–1218
Washington PM, Villapol S, Burns MP (2016) Polypathology and dementia after brain trauma: does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy? Exp Neurol 3:381–388
Venegoni W, Shen Q, Thimmesch AR, Bell M, Hiebert JB, Pierce JD (2017) The use of antioxidants in the treatment of traumatic brain injury. J Adv Nurs 73(6):1331–1338
Abdul-Muneer PM, Schuetz H, Wang F, Skotak M, Jones J, Gorantla S, Zimmerman MC, Chandra N, Haorah J (2013) Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med 60:282–291
de Roos B, Duthie GG (2015) Role of dietary pro-oxidants in the maintenance of health and resilience to oxidative stress. Mol Nutr Food Res 59(7):1229–1248
Albert-Weissenberger C, Sirén AL (2010) Experimental traumatic brain injury. Exp Transl Stroke Med 2:16
Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT (2006) The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J Trauma 60:152–157
Ley EJ, Clond MA, Singer MB, Shouhed D, Salim A (2011) IL6 deficiency affects function after traumatic brain injury. J Surg Res 170(2):253–256
Holmin S, Mathiesen T (2000) Intracerebral administration of interleukin-1beta and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg 92:108–120
Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM (1991) Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 87(4):1360–1366
Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr (1985) Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 121(3):394–403
Frugier T, Morganti-Kossmann MC, O’Reilly D, McLean CA (2010) In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma 27:497–507
Woodcock T, Morganti-Kossmann MC (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:4–18
Vos PE (2011) Biomarkers of focal and diffuse traumatic brain injury. Crit Care 15(4):183
Nylén K, Ost M, Csajbok LZ, Nilsson I, Blennow K, Nellgård B, Rosengren L (2006) Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci 240(1–2):85–91
Kaltschmidt B, Widera D, Kaltschmidt C (2005) Signaling via NF-kappaB in the nervous system. Biochim Biophys Acta 1745:287–299
Laird MD, Vender JR, Dhandapani KM (2008) Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16:154–164
Salminen A, Liu PK, Hsu CY (1995) Alteration of transcription factor binding activities in the ischemic rat brain. Biochem Biophys Res Commun 212:939–944
Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, Smith DH (1999) Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma 16(11):1023–1034
Xiao G, Wei J (2005) Effects of β-Aescin on the expression of nuclear factor-κB and tumor necrosis factor-α after traumatic brain injury in rats. J Zhejiang Univ Sci B 6(1):28–32
Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans 43(4):621–626
Jakubíková J, Sedlák J, Bod’o J, Bao Y (2006) Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells. J Agric Food Chem 54(5):1656–1662
Wagner AE, Boesch-Saadatmandi C, Dose J, Schultheiss G, Rimbach G (2012) Anti-inflammatory potential of allyl-isothiocyanate—role of Nrf2, NF-(κ) B and microRNA-155. J Cell Mol Med 16(4):836–843
Liddell JR (2017) Interplay between Nrf2 and NF-κB in neuroinflammatory diseases. J Clin Cell Immunol 8:489. https://doi.org/10.4172/2155-9899.1000489
Whalen MJ, Carlos TM, Dixon CE, Schiding JK, Clark RS, Baum E, Yan HQ, Marion DW, Kochanek PM (1999) Effect of traumatic brain injury in mice deficient in intercellular adhesion molecule-1: assessment of histopathologic and functional outcome. J Neurotrauma 16:299–309
Bowes MP, Zivin JA, Rothlein R (1993) Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 119:215–219
Knoblach SM, Faden AI (2002) Administration of either anti-intercellular adhesion molecule-1 or a nonspecific control antibody improves recovery after traumatic brain injury in the rat. J Neurotrauma 19:1039–1050
You WC, Wang CX, Pan YX, Zhang X, Zhou XM, Zhang XS, Shi JX, Zhou ML (2013) Activation of nuclear factor-κB in the brain after experimental subarachnoid hemorrhage and its potential role in delayed brain injury. PLoS ONE 8(3):e60290
Gorup D, Bohaček I, Miličević T, Pochet R, Mitrečić D, Križ J, Gajović S (2015) Increased expression and colocalization of GAP43 and CASP3 after brain ischemic lesion in mouse. Neurosci Lett 597:176–182
Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, Julius D (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124(6):1269–1282
Bautista DM, Pellegrino M, Tsunozaki M (2013) TRPA1: a gatekeeper of inflammation. Annu Rev Physiol 75:181–200
Corrigan F, Mander KA, Leonard AV, Vink R (2016) Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflamm 13(1):264
Sun J, Ramnath RD, Zhi L, Tamizhselvi R, Bhatia M (2008) Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol 294(6):C1586–C1596
Acknowledgements
This study was supported by OmniActive Health Technologies Ltd. NJ, USA. This work was also supported in part by The Turkish Academy of Sciences (TUBA) (KS, EK).
Funding
This study was supported by OmniActive Health Technologies Inc. (NJ, USA). This work was also supported in part by the Turkish Academy of Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Caglayan, B., Kilic, E., Dalay, A. et al. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Mol Biol Rep 46, 241–250 (2019). https://doi.org/10.1007/s11033-018-4465-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-018-4465-4